SummaryPotent topical corticosteroids have been documented as causing Cushing's syndrome and hypothalamo‐pituitary‐adrenal suppression. This can be minimized by restriction of potent preparations to specialists and by using these compounds for a minimum, but effective period. If potent corticosteroids are used for prolonged periods, then hypothalamo‐pituitary suppression should be excluded or confirmed by a metyrapone
展开▼